The fact that CK1 activity is needed in Wnt/β-catenin and SHH signaling suggested that mutations in DDX3X might affect CK1 activity and that this could be the reason why they cluster in the Wnt and SHH medulloblastoma tumor groups. This evidence concerns the gene CSNK1A1 and medulloblastoma.